International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Utility of urinary uric acid and creatinine ratio as a marker of neonatal asphyxia: a comparative assessment

Yazarlar: Sujit Kumar Baranala, Nitish Kumar

Cilt 3 , Sayı 3 , 2020 , Sayfalar 149-153

Konular:-

Anahtar Kelimeler:UA/Cr,Biomarker,Birth asphyxia

Özet: Aim: to assess the utility of urine uric acid creatinine ratio (UA/Cr) as an additional marker of neonatal depression and birth asphyxia and it’s utility as a potential prognostic indicator for the immediate outcome. Material and methods: This prospective observational study was carried out in the Department of Pediatrics, Kalawati Saran Children Hospital, New Delhi, India for 1 year in this study that included 200 newborns born. Newborns with encephalopathy were considered to have an unfavourable outcome. The urine UA/Cr was estimated in both groups. Results: The mean differences of urine UA/Cr were statistically significant in birth asphyxia (3.26±1.37), and controls (2.02± 0.71). Conclusion: The urine UA/Cr is a useful diagnostic and prognostic biomarker in newborns with birth asphyxia. Keywords: UA/Cr, Biomarker, Birth asphyxia


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={Utility of urinary uric acid and creatinine ratio as a marker of neonatal asphyxia: a comparative assessment}, volume={3}, number={149–153}, publisher={International Journal of Health and Clinical Research}, author={Sujit Kumar Baranala,Nitish Kumar}, year={2020} }
APA
KOPYALA
Sujit Kumar Baranala,Nitish Kumar. (2020). Utility of urinary uric acid and creatinine ratio as a marker of neonatal asphyxia: a comparative assessment (Vol. 3). Vol. 3. International Journal of Health and Clinical Research.
MLA
KOPYALA
Sujit Kumar Baranala,Nitish Kumar. Utility of Urinary Uric Acid and Creatinine Ratio as a Marker of Neonatal Asphyxia: A Comparative Assessment. no. 149–153, International Journal of Health and Clinical Research, 2020.